Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$97.75 - $129.67 $615,825 - $816,920
-6,300 Reduced 61.76%
3,900 $495 Million
Q2 2024

Aug 14, 2024

BUY
$85.28 - $112.6 $298,480 - $394,100
3,500 Added 52.24%
10,200 $1.1 Billion
Q1 2024

May 15, 2024

BUY
$59.21 - $92.9 $396,707 - $622,430
6,700 New
6,700 $613 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Crawford Fund Management, LLC Portfolio

Follow Crawford Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crawford Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crawford Fund Management, LLC with notifications on news.